(Q50786458)

19 March 2018

title

Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. (English)

1 reference

19 March 2018

metabolic dysfunction–associated steatotic liver disease

main subject

1 reference

1

1 reference

19 March 2018

Fiorella Piemonte

4

1 reference

19 March 2018

Andrea Masotti

9

1 reference

19 March 2018

Nadia Panera

Nadia Panera

5

0 references

Valerio Nobili

Valerio Nobili

10

0 references

Rita De Vito

6

Rita De Vito

1 reference

19 March 2018

Giovannella Bruscalupi

3

Giovannella Bruscalupi

1 reference

19 March 2018

Gian Franco Bottazzo

8

Gian Franco Bottazzo

1 reference

19 March 2018

Silvia Leoni

7

Silvia Leoni

1 reference

19 March 2018

author name string

Letizia Da Sacco

2

1 reference

19 March 2018

publication date

18 October 2010

1 reference

19 March 2018

published in

Laboratory Investigation

1 reference

19 March 2018

volume

91

1 reference

19 March 2018

issue

2

1 reference

19 March 2018

page(s)

283-293

1 reference

19 March 2018

Epidemiology and natural history of non-alcoholic steatohepatitis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Pathologic assessment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Definition and natural history of metabolic steatosis: histology and cellular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Molecular mechanisms involved in NAFLD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Recent advances in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

microRNAs in vertebrate physiology and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNAs and cancer: past, present, and potential future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNAs and the regulation of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Developmental biology. Encountering microRNAs in cell fate signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNAs in diabetes: tiny players in big disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Emerging role of microRNAs in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNA signatures in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Differential expression of microRNAs in mouse liver under aberrant energy metabolic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Treatment with EGF increases the length of S-Phase after partial hepatectomy in rat, changing the activities of cdks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Systematic identification of microRNA functions by combining target prediction and expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Cell-type-specific signatures of microRNAs on target mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Genetics of alcoholic liver disease and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Integration of microRNA miR-122 in hepatic circadian gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

LPS increases hepatic HIF-1alpha protein and expression of the HIF-1-dependent gene aldolase A in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Putative dual role of ephrin-Eph receptor interactions in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

MicroRNA function: multiple mechanisms for a tiny RNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Microarray technology: a promising tool in nutrigenomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

Bioinformatics as tool to identify gene/protein-pathways associated with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

Profiling microRNA expression: A snapshot of nonalcoholic steatohepatitis and a recording of its pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

Toll-like receptor 4: A starting point for proinflammatory signals in fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.166

7 January 2021

10.1038/LABINVEST.2010.166

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018